BioCentury
ARTICLE | Company News

Alnylam, Eurogentec deal

July 18, 2005 7:00 AM UTC

ALNY granted Eurogentec a non-exclusive license to its RNAi patents, for use in developing research products. The patents cover siRNAs and their use to mediate RNAi in mammalian cells. ...